India
· Delayed Price · Currency is INR Laurus Labs Company Description
Laurus Labs Limited, together with its subsidiaries, manufactures and sells medicines and active pharmaceutical ingredients (APIs) in India and internationally.
The company offers Generics APIs and oral solid formulations for advanced intermediates for anti-retroviral (ARV), antidiabetic, cardiovascular, anti-asthma, ophthalmology, oncology, gastroenterology, and hepatitis C therapeutic areas.
It also provides biotechnology services used in the nutraceutical, dietary supplements, alternate food proteins, and cosmeceutical products.
In addition, the company develops novel enzymatic solutions for industrial biotechnology, and animal origin free recombinant proteins and enzymes for biopharma; and offers business support services for pharmaceuticals field.
Laurus Labs Limited was incorporated in 2005 and is based in Hyderabad, India.
| Country | India |
| Founded | 2005 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 6,007 |
| CEO | Satyanarayana Chava |
Contact Details
Address: Serene Chambers Hyderabad, Andhra Pradesh 500034 India | |
| Phone | 91 40 3980 4333 |
| Website | lauruslabs.com |
Stock Details
| Ticker Symbol | LAURUSLABS |
| Exchange | National Stock Exchange of India |
| Fiscal Year | April - March |
| Reporting Currency | INR |
| ISIN Number | INE947Q01028 |
| SIC Code | 2833 |
Key Executives
| Name | Position |
|---|---|
| Dr. Satyanarayana Chava M.Sc., Ph.D. | Chief Executive Officer and Whole Time Director |
| Vantaram Venkata Ravi Kumar Dip in Mgmt., DIS, F.C.M.A. | Chief Financial Officer and Whole-Time Director |